Obesity and the skin

British Journal of Dermatology

Volumn 165, Issue 4, 2011, Pages 743-750

  Shipman, A R ^a   Millington, G W M ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLATION STIMULATING PROTEIN; ADIPOCYTOKINE; ADIPONECTIN; ANDROGEN; DEXFENFLURAMINE; FATTY ACID; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 6; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PLASMINOGEN ACTIVATOR INHIBITOR; RESISTIN; SEX HORMONE BINDING GLOBULIN; TETRAHYDROLIPSTATIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACANTHOSIS NIGRICANS; ACNE; ADIPOSE TISSUE; ANEMIA; ATHEROSCLEROSIS; ATOPIC DERMATITIS; BODY WEIGHT; BROWN ADIPOSE TISSUE; CARCINOGENESIS; DRUG ERUPTION; DRUG WITHDRAWAL; DUPUYTREN CONTRACTURE; FEVER; GENITAL PRURITUS; GRANULOMA ANNULARE; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; JEJUNOILEAL BYPASS; KERATODERMA; KIDNEY FAILURE; LEUKOPLAKIA; LICHEN PLANUS; LYMPHEDEMA; MELANOMA; MYALGIA; NECROBIOSIS LIPOIDICA; OBESITY; PALMOPLANTAR KERATODERMA; POLYARTHRITIS; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; PSORIASIS; PULMONARY HYPERTENSION; REVIEW; SCLERODERMA; SKIN; SKIN CANCER; SKIN DISEASE; SKIN INFECTION; SKIN ULCER; STRIA; SUBCUTANEOUS FAT; TENOSYNOVITIS; VALVULAR HEART DISEASE; VASCULAR DISEASE; VITILIGO; WHITE ADIPOSE TISSUE; WOUND HEALING;

ADIPOKINES; ADIPOSE TISSUE; ANTI-OBESITY AGENTS; BARIATRIC SURGERY; DIABETES COMPLICATIONS; HUMANS; HYPERANDROGENISM; OBESITY; SKIN DISEASES; VASCULAR DISEASES; WOUND HEALING;

EID: 80053501588     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10393.x     Document Type: Review

References (138)

1. National Audit Office. Tackling Obesity in England. London: Stationery Office, 2001; 11-12.
2. Lois K, Kumar S,. Obesity and diabetes. Endocrinol Nutr 2009; 56 (Suppl. 4): 38-42.
3. Guo S, Dipietro LA,. Factors affecting wound healing. J Dent Res 2010; 89: 219-29.
4. Mekkes JR, Loots MA, van der Wal AC, Bos JD,. Causes, investigation and treatment of leg ulceration. Br J Dermatol 2003; 148: 388-401. (Pubitemid 36461316)
5. Bremmer S, van Voorhees AS, Hsu S, et al. Obesity and psoriasis: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol 2010; 63: 1058-69.
6. Labrie F, Luu-The V, Labrie C, et al. Intracrinology and the skin. Horm Res 2000; 54: 218-29. (Pubitemid 34701727)
7. Yosipovitch G, DeVore A, Dawn A,. Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol 2007; 56: 901-16. (Pubitemid 46720212)
8. Suárez-Varela MM, Alvarez LG, Kogan MD, et al. Diet and prevalence of atopic eczema in 6 to 7-year-old schoolchildren in Spain: ISAAC phase III. J Investig Allergol Clin Immunol 2010; 20: 469-75.
9. Kirkpatrick CS, White E, Lee J,. Case-control study of malignant melanoma in Washington State II. Diet, alcohol, and obesity. Am J Epidemiol 1994; 139: 869-80. (Pubitemid 24138390)
10. Mohamed-Ali V, Pinkney JH, Coppack SW,. Adipose tissue as an endocrine and paracrine organ. Int J Obes 1998; 22: 1145-58. (Pubitemid 28548534)
11. Ahima RS, Flier JS,. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11: 327-32.
12. Guzik TJ, Mangalat D, Korbut R,. Adipocytokines-novel link between inflammation and vascular function? J Physiol Pharmacol 2006; 57: 505-28. (Pubitemid 46096102)
13. Poeggeler B, Schulz C, Pappolla MA, et al. Leptin and the skin: a new frontier. Exp Dermatol 2010; 19: 12-18.
14. Poglio S, De Toni-Costes F, Arnaud E, et al. Adipose tissue as a dedicated reservoir of functional mast cell progenitors. Stem Cells 2010; 28: 2065-72.
15. Lidell ME, Enerbäck S,. Brown adipose tissue-a new role in humans? Nat Rev Endocrinol 2010; 6: 319-25.
16. Guida B, Nino M, Perrino NR, et al. The impact of obesity on skin disease and epidermal permeability barrier status. J Eur Acad Dermatol Venereol 2009; 24: 191-5.
17. Loffler H, Aramaki JU, Effendy I,. The influence of body mass index on skin susceptibility to sodium lauryl sulphate. Skin Res Technol 2002; 8: 19-22. (Pubitemid 34555460)
18. Francischetti EA, Tibirica E, da Silva EG, et al. Skin capillary density and microvascular reactivity in obese subjects with and without metabolic syndrome. Microvasc Res 2011; 81: 325-30.
19. Black MM, Bottoms E, Shuster S,. Skin collagen and thickness in simple obesity. BMJ 1971; 4: 149-50.
20. Stallone DD, Stunkard AJ, Zweiman B, et al. Decline in delayed-type hypersensitivity response in obese women following weight reduction. Clin Diagn Lab Immunol 1994; 1: 1202-5.
21. Wang P, Mariman E, Renes J, Keijer J,. The secretory function of adipocytes in the physiology of white adipose tissue. J Cell Physiol 2008; 216: 3-13. (Pubitemid 351813090)
22. Scheinfeld NS,. Obesity and dermatology. Clin Dermatol 2004; 22: 303-9. (Pubitemid 39314615)
23. Wild R,. Obesity, lipids, cardiovascular risk and androgen excess. Am J Med 1995; 98: 275-325.
24. Bellon JM, Duran HJ,. Biological factors involved in the genesis of incisional hernia. Cir Esp 2008; 83: 3-7.
25. Puzziferri N, Austrheim-Smith IT, Wolfe BM, et al. Three-year follow-up of a prospective randomized trial comparing laparoscopic versus open gastric bypass. Ann Surg 2006; 243: 181-8. (Pubitemid 43185436)
26. Nguyen NT, Ho HS, Palmer LS, Wolfe BM,. A comparison study of laparoscopic versus open gastric bypass for morbid obesity. J Am Coll Surg 2000; 191: 149-55.
27. Millington GWM,. The role of proopiomelanocortin (POMC) neurones in feeding behaviour. Nutr Metab 2007; 4: 18.
28. Fantuzzi G,. Three questions about leptin and immunity. Brain Behav Immun 2009; 23: 405-10.
29. Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007; 157: 68-73. (Pubitemid 46934281)
30. Huang YH, Yang LC, Hui RY, et al. Relationship between obesity and the clinical severity of psoriasis in Taiwan. J Eur Acad Dermatol Venereol 2010; 24: 1035-9.
31. Bardazzi F, Balestri R, Baldi E, et al. Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy. Dermatol Ther 2010; 23: S14-19.
32. Driessen RJB, Boezeman JB, van de Kerkhof PCM, de Jong EMGJ,. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies. J Dermatolog Treat 2009; 20: 42-7.
33. Murray ML, Bergstresser PR, Adams-Huet B, Cohen JB,. Relationship of psoriasis severity to obesity using same-gender siblings as controls for obesity. Clin Exp Dermatol 2008; 34: 140-4.
34. Sterry W, Strober BE, Menter A,. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol 2007; 157: 649-55. (Pubitemid 47389868)
35. Setty AR, Curhan G, Choi HK,. Obesity, waist circumference, weight change and the risk of psoriasis in women: Nurses Health Study II. Arch Intern Med 2007; 167: 1670-5. (Pubitemid 47280349)
36. Boccardi D, Menni S, La Vecchia C, et al. Overweight and childhood psoriasis. Br J Dermatol 2009; 161: 470-92.
37. Soltani-Arabshahi R, Wong B, Feny BJ, et al. Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol 2010; 146: 721-6.
38. Gelfand JM, Gladman D, Mease P, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005; 53: 573.
39. Kaye JA, Li L, Jick SS,. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 2008; 159: 895-902.
40. Shapiro J, Cohen D, David M, et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007; 56: 629-34. (Pubitemid 46400186)
41. Channual J, Wu JJ, Dann FJ,. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis. Dermatol Ther 2009; 22: 61-73.
42. Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-41. (Pubitemid 44547793)
43. Prodanovich S, Kirsner RS, Kravetz JD, et al. Association of psoriasis with coronary artery, cerebrovascular and peripheral vascular diseases and mortality. Arch Dermatol 2009; 146: 700-3.
44. Gulliver W,. Long-term prognosis in patients with psoriasis. Br J Dermatol 2008; 159 (Suppl. 2): 2-9.
45. Lotti T, Hercogova J, Prignano F,. The concept of psoriatic disease: can cutaneous psoriasis any longer be separated by the systemic comorbidities? Dermatol Ther 2010; 25: 119-22.
46. Alexandroff AB, Pauriah M, Camp RDR, et al. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis. Br J Dermatol 2009; 161: 1-7.
47. Menter A, Griffiths CEM, Tebbey PW, et al. Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community. J Eur Acad Dermatol Venereol 2010; 24: 1371-7.
48. Prodanovich S, Shelling ML, Federman DG, Kirsner RS,. Cytokine milieu in psoriasis and cardiovascular disease may explain the epidemiological findings relating these 2 diseases. Arch Dermatol 2008; 144: 1518-19.
49. Chen YJ, Wu CY, Shen JL, et al. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermatol 2008; 144: 1571-5.
50. Qureshi AA, Choi HK, Setty AR, Curham GC,. Psoriasis and the risk of diabetes and hypertension. Arch Dermatol 2009; 145: 379-82.
51. Alsufyani MA, Golant AK, Lebwohl M,. Psoriasis and the metabolic syndrome. Dermatol Ther 2010; 23: 137-43.
52. Herron MD, Hinckly M, Hoffman S, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527-34. (Pubitemid 41815842)
53. Bandoli G, Johnson DL, Jones KL, et al. Potentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasis. Br J Dermatol 2010; 163: 334-9.
54. Hercogova J, Ricceri F, Tripo L, et al. Psoriasis and body mass index. Dermatol Ther 2010; 23: 152-4.
55. Perez-Perez I, Allegue F, Caeiro JI, et al. Severe psoriasis, morbid obesity and bariatric surgery. Clin Exp Dermatol 2009; 34: e421-2.
56. Rucevic I, Perl A, Barisic-Drusko V, Adam-Perl M,. The role of the low energy diet in psoriasis vulgaris treatment. Coll Antropol 2003; 27 (Suppl. 1): 41-8. (Pubitemid 38340151)
57. Higa-Sansone G, Szomstein S, Soto F, et al. Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2004; 14: 1132-4. (Pubitemid 39299743)
58. Hossler EW, Maroon MS, Mowad CM,. Gastric bypass surgery improves psoriasis. J Am Acad Dermatol 2011; 65: 198-200.
59. Federman DG, Shelling M, Prodanovich S, et al. Psoriasis: an opportunity to identify cardiovascular risk. Br J Dermatol 2009; 160: 1-7.
60. Song AY, Rubin JP, Thomas V, et al. Body image and quality of life in post massive weight loss body contouring patients. Obesity 2006; 14: 1626-36. (Pubitemid 46214830)
61. Ceman AA, Bozkurt S, Sav A, et al. Serum leptin levels, skin leptin and leptin receptor expression in psoriasis. Br J Dermatol 2008; 159: 820-6.
62. Johnston A, Arnadottir S, Gudjonsson JE, et al. Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol 2008; 159: 342-50. (Pubitemid 352009847)
63. Boehncke S, Thaci D, Beschmann H, et al. Psoriasis patients show signs of insulin resistance. Br J Dermatol 2007; 157: 1249-51. (Pubitemid 350115673)
64. Coimbra S, Oliveira H, Reis F, et al. Circulating adipokine levels in Portugese patients with psoriasis vulgaris according to body mass index, severity and therapy. J Eur Acad Dermatol Venereol 2010; 24: 1386-94.
65. Kaur S, Zilmer K, Kairane C, et al. Clear differences in adiponectin level and glutathione redox status revealed in obese and normal weight patients with psoriasis. Br J Dermatol 2008; 159: 1364-7.
66. Tabor CA, Parlette EC,. Cutaneous manifestations of diabetes. Signs of poor glycemic control or new-onset disease. Postgrad Med 2006; 119: 38-44.
67. Perez MI, Kohn SR,. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 1994; 4: 519-33.
68. Brickman WJ, Binns HJ, Jovanovic BD, et al. Acanthosis nigricans: a common finding in overweight youth. Pediatr Dermatol 2007; 24: 601-6. (Pubitemid 350173677)
69. Verma SB, Wollina U,. Acne keloidalis nuchae: another cutaneous symptom of metabolic syndrome, truncal obesity, and impending/overt diabetes mellitus? Am J Clin Dermatol 2010; 11: 433-6.
70. Berk DR, Spector EB, Bayliss SJ,. Familial acanthosis nigricans due to K650T FGFR3 mutation. Arch Dermatol 2007; 143: 1153-6. (Pubitemid 47443367)
71. Rasi A, Soltani-Arabshani R, Shahbazi N,. Skin tag as a cutaneous marker for impaired carbohydrate metabolism: a case control study. Int J Dermatol 2007; 46: 1155-9. (Pubitemid 350055886)
72. El Safoury O, Fawzi M, Abdel Hay RM, et al. Increased tissue leptin hormone level and mast cell count in skin tags: a possible role of adipoimmune in the growth of benign skin growths. Indian J Dermatol Venereol Leprol 2010; 76: 538-42.
73. Garciá-Hidalgo L, Orozco-Topete R, Gonzalez-Barranco J, et al. Dermatoses in 156 obese adults. Obes Res 1999; 7: 299-302. (Pubitemid 129710590)
74. Lowenstein EJ,. Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome. Dermatol Ther 2006; 19: 210-23. (Pubitemid 44386588)
75. Jones RH, Carek PJ,. Management of varicose veins. Am Fam Physician 2008; 78: 1289-94.
76. van Gent WB, Wilschut ED, Wittens C,. Management of venous ulcer disease. BMJ 2010; 341: c6045.
77. Guneli E, Gumustekin M, Ates M,. Possible involvement of ghrelin on pain threshold in obesity. Med Hypotheses 2010; 74: 452-4.
78. Drake DJ, Swanson M, Baker G, et al. The association of BMI and Braden total score on the occurrence of pressure ulcers. J Wound Ostomy Continence Nurs 2010; 37: 367-71.
79. Janigan DT, Prokopetz RD, Chawla S, Durning RG,. Massive necrosis of fat and skin as complication of obesity. CMAJ 1989; 140: 665-8. (Pubitemid 19093375)
80. Wang Y, Oliver G,. Current views on the function of the lymphatic vasculature in health and disease. Genes Dev 2010; 24: 2115-26.
81. Garciá-Hidalgo L,. Dermatological complications of obesity. Am J Clin Dermatol 2002; 3: 497-506.
82. Weston S, Clay CD,. Unusual case of lymphoedema in a morbidly obese patient. Australas J Dermatol 2007; 48: 115-19. (Pubitemid 46802053)
83. Sreeramoju P, Porbandarwalla NS, Arango J, et al. Recurrent skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus requiring operative debridement. Am J Surg 2011; 201: 216-20.
84. Havlickova B, Czaika VA, Freidrich M,. Epidemiological trends in skin mycoses worldwide. Mycoses 2008; 51 (Suppl. 4): 2-15.
85. Kilburn SA, Featherstone P, Higgins B, Brindle R,. Interventions for cellulitis and erysipelas. Cochrane Database Syst Rev 2010; 6: CD004299.
86. Baird D, Bode D, Akers T, DeYoung Z,. Elephantiasis nostras verrucosa: a complication of congestive heart failure and obesity. J Am Board Fam Med 2010; 23: 413-17.
87. Sibbald RG, Schachter RK,. The skin and diabetes mellitus. Int J Dermatol 1984; 23: 567-84. (Pubitemid 15219374)
88. Light TD, Choi KC, Thomsen TA, et al. Long-term outcomes of patients with necrotizing fasciitis. J Burn Care Res 2010; 31: 93-9.
89. Le Hello S, Doloy A, Baumann F, et al. Clinical and microbial characteristics of invasive Streptococcus pyogenes disease in New Caledonia, a region in Oceania with a high incidence of acute rheumatic fever. J Clin Microbiol 2010; 48: 526-30.
90. Eliakim A, Swindt C, Zaldivar F, et al. Reduced tetanus antibody titers in overweight children. Autoimmunity 2006; 39: 137-41. (Pubitemid 43675257)
91. Ellison JA, Patel L, Kecojevic T, et al. Pattern of growth and adiposity from infancy to adulthood in atopic dermatitis. Br J Dermatol 2006; 155: 532-8. (Pubitemid 44215482)
92. Murray CS, Canoy D, Buchan I, et al. Body mass index in young children and allergic disease: gender differences in a longitudinal study. Clin Exp Allergy 2011; 41: 78-85.
93. Hersoug LG, Linneberg A,. The link between the epidemics of obesity and allergic diseases: does obesity induce decreased immune tolerance? Allergy 2007; 62: 1205-13. (Pubitemid 47374032)
94. Radon K, Schulze A, Schierl R, et al. Serum leptin and adiponectin levels and their association with allergic sensitization. Allergy 2008; 63: 1448-54.
95. Oh SW, Yoon YS, Shin S,. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation study. J Clin Oncol 2005; 23: 4742-54. (Pubitemid 46224078)
96. Daling J, Malone KE, Doody DR, et al. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 2001; 92: 720-9. (Pubitemid 32783055)
97. Courneya KS, Katzmarzyk PT, Bacon E,. Physical activity and obesity in Canadian cancer survivors: population-based estimates from the 2005 Canadian Community Health Survey. Cancer 2008; 112: 2475-82.
98. Olsen CM, Hughes MC, Pandeya N, Green AC,. Anthropometric measures in relation to basal cell carcinoma: a longitudinal study. BMC Cancer 2006; 6: 82.
99. Samanic C, Gridley G, Chow WH, et al. Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 2004; 15: 35-43. (Pubitemid 38339970)
100. Samanic C, Chow WH, Gridley G, et al. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 2006; 17: 901-9. (Pubitemid 44078281)
101. Dubin N, Moseson M, Pasternack BS,. Epidemiology of malignant melanoma: pigmentary traits, ultraviolet radiation, and the identification of high-risk populations. Recent Results Cancer Res 1986; 102: 56-75.
102. Gallus S, Naldi L, Martin L, et al. Anthropometric measures and risk of cutaneous malignant melanoma: a case-control study from Italy. Melanoma Res 2006; 16: 83-7. (Pubitemid 44133056)
103. Dennis LK, Lowe JB, Lynch CF, Alavanja MC,. Cutaneous melanoma and obesity in the Agricultural Health Study. Ann Epidemiol 2008; 18: 214-21. (Pubitemid 351232237)
104. Veierod MB, Thelle DS, Laake P,. Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women. Int J Cancer 1997; 71: 600-4. (Pubitemid 27239370)
105. Millington GWM,. Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors. Clin Exp Dermatol 2006; 31: 407-12.
106. Comuzzie AG, Hixson JE, Almasy L, et al. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 1997; 15: 273-6. (Pubitemid 27098721)
107. Hixson JE, Almasy L, Cole S, et al. Normal variation in leptin levels is associated with polymorphisms in the proopiomelanocortin gene, POMC. J Clin Endocrinol Metab 1999; 84: 3187-91. (Pubitemid 30646942)
108. Farooqi IS, Drop S, Clements A, et al. Heterozygosity for a POMC-null mutation and increased obesity risk in humans. Diabetes 2006; 55: 2549-53. (Pubitemid 44871155)
109. Nan H, Kraft P, Hunter DJ, Han J,. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians. Int J Cancer 2009; 125: 909-17.
110. Sharma SD, Katiyar SK,. Leptin deficiency-induced obesity exacerbates ultraviolet B radiation-induced cyclooxygenase-2 expression and cell survival signals in ultraviolet B-irradiated mouse skin. Toxicol Appl Pharmacol 2010; 244: 328-35.
111. Fennoy I,. Metabolic and respiratory comorbidities of childhood obesity. Pediatr Ann 2010; 39: 140-6.
112. De Leyn P, Bedert L, Delcroix M, et al. Tracheotomy: clinical review and guidelines. Eur J Cardiothorac Surg 2007; 32: 412-21. (Pubitemid 47223715)
113. Chapman DM, Boskey AL, Tesch M, et al. Subcutaneous microvascular (capillary) calcification, another basis for livedo-like skin changes? Clin Exp Dermatol 1995; 20: 213-17.
114. McNaughton F, Keczkes K,. Scleredema adultorum and diabetes mellitus (scleredema diutinum). Clin Exp Dermatol 1983; 8: 41-5. (Pubitemid 13225313)
115. Monk BE, Pembroke AC, Vollum DI,. Scleroedema of Bushke and diabetes mellitus: a report of two cases. Clin Exp Dermatol 1983; 8: 389-91. (Pubitemid 13068663)
116. Parker SC, Fenton DA, Black MM,. Scleredema. Clin Exp Dermatol 1989; 14: 385-6. (Pubitemid 19223005)
117. Woollons A, Darley CR, Lee PJ, et al. Cutis verticis gyrata of the scalp in a patient with autosomal dominant insulin resistance syndrome. Clin Exp Dermatol 2000; 25: 125-8. (Pubitemid 30212420)
118. Cubukçu A, Gönüllü NN, Paksoy M, et al. The role of obesity on the recurrence of pilonidal sinus disease in patients, who were treated by excision and Limberg flap transposition. Int J Colorectal Dis 2000; 15: 173-5.
119. Dowlati B, Firooz A, Khamesipour A, et al. Insulin quantification in patients with seborrheic dermatitis. Arch Dermatol 1998; 134: 1043-4.
120. Guarneri C, Guarneri F, Borgia F, Vaccaro M,. Finger pebbles in diabetic patient: Huntley's papules. Int J Dermatol 2005; 44: 755-6. (Pubitemid 41301011)
121. Tamiya H, Tsuruta D, Umeda R, et al. Keratosis follicularis squamosa (Dohi) associated with pseudoacanthosis nigricans. Br J Dermatol 2004; 150: 603-5. (Pubitemid 38446328)
122. Chamberlain AJ, Tam MM,. Intertriginous granular parakeratosis responsive to potent topical corticosteroids. Clin Exp Dermatol 2003; 28: 50-2. (Pubitemid 36197564)
123. Fatourechi V,. Pretibial myxedema: pathophysiology and treatment options. Am J Clin Dermatol 2005; 6: 295-309. (Pubitemid 41577404)
124. Rongioletti F, Donati P, Amantea A, et al. Obesity associated lymphoedematous mucinosis. J Cutan Pathol 2009; 36: 1089-94.
125. Tokuda Y, Kawachi S, Murata H, et al. Chronic obesity lymphoedematous mucinosis: three cases of pretibial mucinosis in obese patients with pitting oedema. Br J Dermatol 2006; 154: 157-61. (Pubitemid 43381337)
126. Beard MP, Millington GWM,. Recent developments in the specific dermatoses of pregnancy. Clin Exp Dermatol (in press).
127. Wortham NC, Tomlinson IP,. Dercum's disease. Skinmed 2005; 4: 157-62.
128. Campen R, Mankin H, Louis DN, et al. Familial occurrence of adiposis dolorosa. J Am Acad Dermatol 2001; 44: 132-6. (Pubitemid 32110578)
129. Patel S, Zirwas M, English JC,. Acquired palmoplantar keratoderma. Am J Clin Dermatol 2007; 8: 1-11. (Pubitemid 46998558)
130. Radmanesh M,. Erythema ab igne following sauna belt use for abdominal obesity and cellulite. Int J Dermatol 2009; 48: 94-5.
131. Salavert M, Amarger S, Ferrier Le Bouedec MC, et al. Allergic contact dermatitis to guggul in a slimming cream. Contact Dermatitis 2007; 56: 286-99.
132. Papadavid E, Yu RC, Tay A, Chu AC,. Urticarial vasculitis induced by centrally acting appetite suppressants. Br J Dermatol 1996; 134: 990-1. (Pubitemid 26150313)
133. Sergeant A, Milne G, Shaffrali F,. Lichenoid eruption associated with orlistat. Br J Dermatol 2006; 154: 1020-1.
134. Tu J, Chan JJ, Lawrence LY,. Bowel bypass syndrome/bowel-associated dermatosis arthritis syndrome post laparoscopic gastric bypass surgery. Australas J Dermatol 2011; 52: e5-7.
135. Kennedy C,. The spectrum of inflammatory skin disease following jejuno-ileal bypass for morbid obesity. Br J Dermatol 1981; 105: 425-35. (Pubitemid 11026250)
136. Ahmed AR, Drenick E,. Cutaneous immunofluorescence studies in bowel bypass syndrome. Clin Exp Dermatol 1982; 7: 477-83. (Pubitemid 12058157)
137. Slater GH, Kerlin P, Georghiou PR, et al. Bowel-associated dermatosis-arthritis syndrome after biliopancreatic diversion. Obes Surg 2004; 14: 133-5. (Pubitemid 38130731)
138. Katugampola RP, Patel GK, Farrell AM,. Intestinal bypass syndrome presenting as erythema nodosum. Clin Exp Dermatol 2004; 29: 261-4. (Pubitemid 38658466)